How do the newer oral antimicrobials stack up against traditional agents?
As the antibiotic arsenal expands with the development of new oral agents, selecting appropriate therapy is becoming more difficult. What are the therapeutic indications for the newer antimicrobials, and what advantages do they have over traditional agents? Drs Gleckman and De La Rosa discuss current issues related to antibiotic treatment and offer specific recommendations for the best use of the newer agents.
Gleckman
R
R
Department of Medicine, St Joseph's Hospital and Medical Center, Paterson, NJ 07503, USA. gleckman@sjhmc.org
De La Rosa
G
G
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use; D024841:Fluoroquinolones; D005578:Fosfomycin / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D018942:Macrolides; D010349:Patient Compliance; D014325:Tromethamine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002511:Cephalosporins; D024841:Fluoroquinolones; D018942:Macrolides; D014325:Tromethamine; D005578:Fosfomycin